Cumberland Pharmaceuticals Inc.
 Booth Number:   2449

Cumberland Pharmaceuticals Inc. manufactures AcetadoteĀ®(acetylcysteine) Injection for acetaminophen overdose. Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury. Acetadoteā€™s 2008 labeling includes post-marketing safety data.

2525 West End Avenue
Suite 950
Nashville, TN 37203
United States
www.cumberlandpharma.com

Your Feedback